H.B. Fuller Valuation Multiples

Discover H.B. Fuller's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Hawkins, Solvay, Clariant, Ashland and more.

H.B. Fuller Overview

About H.B. Fuller

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.


Founded

1915

HQ

United States

Employees

7.5K

Sectors

Financials (LTM)

Revenue: $3.6B
EBITDA: $650M

EV

$5B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

H.B. Fuller Financials

H.B. Fuller reported last 12-month revenue of $3.6B and EBITDA of $650M.

In the same LTM period, H.B. Fuller generated $1.2B in gross profit, $650M in EBITDA, and $257M in net income.

Revenue (LTM)


H.B. Fuller P&L

In the most recent fiscal year, H.B. Fuller reported revenue of $3.5B and EBITDA of $621M.

H.B. Fuller is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 18%, and net margin of 7%.

See analyst estimates for H.B. Fuller
LTMLast FY202320242025202620272028
Revenue$3.6B$3.5B$3.5B$3.6B$3.5B
Gross Profit$1.2B$1.1B$1B$1.1B$1.1B
Gross Margin33%31%29%30%31%
EBITDA$650M$621M$525M$494M$539M
EBITDA Margin18%18%15%14%15%
EBIT Margin13%13%11%10%11%
Net Profit$257M$235M$144M$132M$162M
Net Margin7%7%4%4%5%
Net Debt-$1.9B---

Financial data powered by Morningstar, Inc.

H.B. Fuller Stock Performance

H.B. Fuller has current market cap of $3.1B, and enterprise value of $5B.

Market Cap Evolution


H.B. Fuller's stock price is $56.96.

H.B. Fuller share price decreased by 2.3% in the last 30 days, and increased by 1.4% in the last year.

H.B. Fuller has an EPS (earnings per share) of $4.36.

See more trading valuation data for H.B. Fuller
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5B$3.1B0.0%-2.3%-5.9%1.4%$4.36

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

H.B. Fuller Valuation Multiples

H.B. Fuller trades at 1.4x EV/Revenue multiple, and 7.7x EV/EBITDA.

See NTM and 2027E valuation multiples for H.B. Fuller

EV / Revenue (LTM)


H.B. Fuller Financial Valuation Multiples

As of July 19, 2026, H.B. Fuller has market cap of $3.1B and EV of $5B.

H.B. Fuller has a P/E ratio of 11.9x.

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.4x1.4x1.4x1.4x
EV/EBITDA7.7x8.1x9.6x10.2x9.3x
EV/EBIT10.8x11.3x13.4x13.7x13.0x
EV/Gross Profit4.3x4.6x5.0x4.7x4.6x
P/E11.9x13.1x21.3x23.2x18.9x
EV/FCF36.4x38.8x20.0x31.4x40.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified H.B. Fuller Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

H.B. Fuller Margins & Growth Rates

H.B. Fuller grew revenue by 5% and EBITDA by 8% in the last fiscal year.

In the most recent fiscal year, H.B. Fuller reported gross margin of 31%, EBITDA margin of 18%, and net margin of 7%.

See estimated margins and future growth rates for H.B. Fuller

H.B. Fuller Margins

Last FY202420252026202720282029
Gross Margin31%30%31%33%
EBITDA Margin18%14%15%18%
EBIT Margin13%10%11%13%
Net Margin7%4%5%7%
FCF Margin4%4%4%4%

H.B. Fuller Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%1%(2%)5%
Gross Profit Growth13%5%3%11%
EBITDA Growth8%(6%)9%25%
EBIT Growth7%(2%)6%24%
Net Profit Growth15%(8%)23%69%
FCF Growth11%(36%)(23%)20%

Data powered by FactSet, Inc. and Morningstar, Inc.

H.B. Fuller Operational KPIs

H.B. Fuller's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.

H.B. Fuller's Rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

H.B. Fuller's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for H.B. Fuller
LTMLast FY202320242025202620272028
Rule of 4025%23%---
Bessemer Rule of X35%31%---
Revenue per Employee-$0.5M---
Opex per Employee-$0.1M---
G&A Expenses to Revenue-18%17%18%18%
R&D Expenses to Revenue1%2%1%1%2%
Opex to Revenue-20%18%20%20%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

H.B. Fuller Competitors

H.B. Fuller competitors include Hawkins, Solvay, Clariant, Ashland, Azelis Group, K+S, Mitsubishi Materials, Gubre Fabrikalari, Kuraray Co and Enaex.

Most H.B. Fuller public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Hawkins3.0x3.0x18.2x17.8x
Solvay0.9x1.0x4.9x5.3x
Clariant0.9x1.0x5.4x5.7x
Ashland2.3x2.3x10.7x11.0x
Azelis Group1.0x1.0x9.0x9.0x
K+S0.7x0.7x3.5x3.7x
Mitsubishi Materials0.5x0.5x9.9x7.4x
Gubre Fabrikalari2.5x-12.0x-

This data is available for Pro users. Sign up to see all H.B. Fuller competitors and their valuation data.

Start Free Trial

Acquisitions by H.B. Fuller

H.B. Fuller has acquired 13 companies to date.

Last acquisition by H.B. Fuller was on June 24th 2026. H.B. Fuller acquired Advanced Medical Solutions Group for $962M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by H.B. Fuller

Advanced Medical Solutions Group
Advanced Medical Solutions Group
GEM
Medifill
Description
Advanced Medical Solutions Group PLC is engaged in developing, and manufacturing advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical; and Woundcare, of which Surgical segment derives maximum revenue.
Advanced Medical Solutions Group PLC is engaged in developing, and manufacturing advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical; and Woundcare, of which Surgical segment derives maximum revenue.
GEM is an Italian manufacturer of single-use medical devices for dialysis and infusion therapy. Its Vicenza facility produces bloodlines, filters, and bags distributed to hospitals in Europe and Latin America. Certified ISO 13485 since 1992, GEM supplies over 50 clinics annually.
-
HQ CountryUnited KingdomUnited KingdomItalyIreland
HQ City
Winsford
Winsford
Viareggio
-
Deal Date24 Jun 202624 Jun 20262 Dec 20242 Dec 2024
Valuation$962M$962Mundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all H.B. Fuller acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by H.B. Fuller

H.B. Fuller has invested in 1 company to date.

Latest investment by H.B. Fuller was on May 27th 2026. H.B. Fuller invested in Verdafresh in their Strategic investment round.

See VC round multiples

Latest Investments by H.B. Fuller

Verdafresh
Description
Verdafresh is a supplier of sustainable flexible packaging for fresh foods using natural fibers and biobased materials. The company manufactures stand-up pouches, flow-wrap films, and lidding solutions that extend shelf life through breathable properties. Verdafresh also recycles post-consumer packaging and provides digital printing services from its U.S. facilities.
HQ CountryUnited States
HQ City
Philadelphia, PA
Deal Date27 May 2026
RoundStrategic investment
Raisedundisclosed
InvestorsH.B. Fuller
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all H.B. Fuller investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About H.B. Fuller

When was H.B. Fuller founded?H.B. Fuller was founded in 1915.
Where is H.B. Fuller headquartered?H.B. Fuller is headquartered in United States.
How many employees does H.B. Fuller have?As of today, H.B. Fuller has over 7K employees.
Who is the CEO of H.B. Fuller?H.B. Fuller's CEO is Celeste Beeks Mastin.
Is H.B. Fuller publicly listed?Yes, H.B. Fuller is a public company listed on NYSE.
What is the stock symbol of H.B. Fuller?H.B. Fuller trades under FUL ticker.
When did H.B. Fuller go public?H.B. Fuller went public in 1972.
Who are competitors of H.B. Fuller?H.B. Fuller main competitors include Hawkins, Solvay, Clariant, Ashland, Azelis Group, K+S, Mitsubishi Materials, Gubre Fabrikalari, Kuraray Co, Enaex.
What is the current market cap of H.B. Fuller?H.B. Fuller's current market cap is $3.1B.
What is the current revenue of H.B. Fuller?H.B. Fuller's last 12 months revenue is $3.6B.
What is the current revenue growth of H.B. Fuller?H.B. Fuller revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of H.B. Fuller?Current revenue multiple of H.B. Fuller is 1.4x.
What is the current EBITDA of H.B. Fuller?H.B. Fuller's last 12 months EBITDA is $650M.
What is H.B. Fuller's EBITDA margin?H.B. Fuller's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of H.B. Fuller?Current EBITDA multiple of H.B. Fuller is 7.7x.
What is the current FCF of H.B. Fuller?H.B. Fuller's last 12 months FCF is $138M.
What is H.B. Fuller's FCF margin?H.B. Fuller's last 12 months FCF margin is 4%.
What is the current EV/FCF multiple of H.B. Fuller?Current FCF multiple of H.B. Fuller is 36.4x.
How many companies H.B. Fuller has acquired to date?As of July 2026, H.B. Fuller has acquired 12 companies.
What was the largest acquisition by H.B. Fuller?$1.6B acquisition of Royal Adhesives and Sealants on 5th September 2017 was the largest M&A H.B. Fuller has done to date.
What companies H.B. Fuller acquired?H.B. Fuller acquired Royal Adhesives and Sealants, Advanced Medical Solutions Group, Wisdom Adhesives Worldwide, Adhezion Biomedical, Hs Butyl, Fourny, XCHEM International, Advanced Adhesives, GEM, Apollo, and 2 other companies.
In how many companies H.B. Fuller has invested to date?As of July 2026, H.B. Fuller has invested in 1 company.
What was the last H.B. Fuller investment?On 27th May 2026 H.B. Fuller invested in Verdafresh, participating in a Strategic investment round.
In what companies H.B. Fuller invested in?H.B. Fuller invested in Verdafresh.

See public comps similar to H.B. Fuller

Lists including H.B. Fuller

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial